• OPEN AN ACCOUNT
Indian Indices
Nifty
16,170.15 144.35
(0.90%)
Sensex
54,252.53 503.27
( 0.94%)
Bank Nifty
35,094.90 755.40
( 2.20%)
Nifty IT
27,932.55 366.45
( 1.33%)
Global Indices
Nasdaq
11,740.65 305.91
(2.68%)
Dow Jones
32,637.19 516.91
(1.61%)
Hang Seng
20,116.20 -55.07
(-0.27%)
Nikkei 225
26,604.84 -72.96
(-0.27%)
Forex
USD-INR
77.39 -0.05
(-0.06%)
EUR-INR
82.87 0.44
(0.53%)
GBP-INR
97.01 -0.28
(-0.28%)
JPY-INR
0.61 0.00
(0.31%)

EQUITY - MARKET SCREENER

Suven Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543064
INE03QK01018
59.7370714
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUVENPHAR
22.95
12804.62
EPS(TTM)
Face Value()
Div & Yield %
21.92
1
0.99
 

Regent Enterprises Ltd
Regent Enterprises Ltd - Statement Of Investor Complaints For The Quarter Ended June 2021
Jul 20,2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vikas KumarDesignation :- Managing Director / Whole Time Director